Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists
- 12 June 2008
- journal article
- Published by Elsevier BV in Brain Research
- Vol. 1214, 58-72
- https://doi.org/10.1016/j.brainres.2008.03.077
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- A histologically derived stereotaxic atlas and substance P immunohistochemistry in the brain of the least shrew (Cryptotis parva) support its role as a model organism for behavioral and pharmacological researchBrain Research, 2007
- Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptorsBiochemical Pharmacology, 2007
- Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: Comparison with antidepressant drugsPeptides, 2005
- Enteric motor and interneuronal circuits controlling motilityNeurogastroenterology & Motility, 2004
- Pharmacological Profile of (2R-trans)-4-[1-[3,5-bis(Trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an Orally and Centrally Active Neurokinin-1 Receptor AntagonistThe Journal of pharmacology and experimental therapeutics, 2002
- Serotonin 5-HT 3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesisJournal of Neural Transmission, 1998
- Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammationPharmacology & Therapeutics, 1997
- Physiology of Chemotherapy-Induced Emesis and Antiemetic TherapyDrugs, 1997
- Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferretsNeuropharmacology, 1996
- Rôle de la substance P dans le contrôle nerveux de la motricité digestiveArchives Internationales de Physiologie, de Biochimie et de Biophysique, 1991